首页> 美国卫生研究院文献>Haematologica >Comment to the article by Arai Y Jo T Matsui H Kondo T and Takaori-Kondo A: Comparison of up-front treatments for newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis. Haematologica 2018;103(1):163–171. Need to direct immune thrombocytopenia therapy towards shared goals

【2h】

Comment to the article by Arai Y Jo T Matsui H Kondo T and Takaori-Kondo A: Comparison of up-front treatments for newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis. Haematologica 2018;103(1):163–171. Need to direct immune thrombocytopenia therapy towards shared goals

机译：评论Arai YJo TMatsui HKondo T和Takaori-Kondo A的文章：新诊断的免疫性血小板减少症的前期治疗方法比较-系统评价和网络荟萃分析。血液学2018; 103（1）：163-171。需要将免疫性血小板减少症治疗导向共同目标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Haematologica
作者
Lorenzo Cirasino; Stefano Semeraro;
展开▼
作者单位

展开▼
年(卷),期 2018(103),6
年度 2018
页码 e268
总页数 1
原文格式 PDF
正文语种
中图分类血液学检验;
关键词

相似文献

外文文献

1. Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis [J] . Yasuyuki Arai, Tomoyasu Jo, Hiroyuki Matsui, Haematologica . 2018,第1期

机译：新诊断的免疫性血小板减少症的前期治疗方法比较-系统评价和网络荟萃分析
2. Distinct alterations of CD68 + CD163 + M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment [J] . Xia Shao, Boting Wu, Luya Cheng, Journal of Translational Medicine . 2018,第1期

机译：大剂量地塞米松治疗后新诊断的原发性免疫性血小板减少症伴或不伴CR的CD68 + CD163 + M2类巨噬细胞和髓样抑制细胞的明显改变
3. Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis [J] . Jiaxing Zhang, Yi Liang, Yuan Ai, Scientific reports. . 2018,第1期

机译：Eltompagag与romiplostim治疗患有持久性或慢性免疫血小板减少症的儿童：一种系统综述，其掺入间接 - 比较荟萃分析
4. Response to the Comment by Cirasino L and Semeraro S: Need to direct immune thrombocytopenia therapy towards shared goals Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia in adults [O] . Yasuyuki Arai, Tomoyasu Jo, Hiroyuki Matsui, 2018

机译：回应Cirasino L和Semeraro S的评论：需要将免疫性血小板减少症治疗朝着共同的目标发展直接和间接比较是成人新诊断原发性免疫性血小板减少症的首选选择
5. Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis [O] . Jiaxing Zhang, Yi Liang, Yuan Ai, 2018

机译：Eltrompag与Romiplostim治疗成人免疫血小板减少症患者：一种系统综述，其掺入间接比较的荟萃分析

著录项

相似文献

相关主题

期刊订阅